Atogepant for the prevention of episodic migraine in adults
Objective: Atogepant is a newly approved medication for the prevention of migraine. This review aims to discuss the efficacy, safety, cost, and place in therapy of atogepant. Methods: The authors performed a systematic search for sources, including articles, abstracts, and poster presentations. Quer...
| Główni autorzy: | , , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
SAGE Publishing
2022-10-01
|
| Seria: | SAGE Open Medicine |
| Dostęp online: | https://doi.org/10.1177/20503121221128688 |